Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

9.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.4K
Autophagic Cell Death01:18

Autophagic Cell Death

4.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biohybrid cochlear implants: neural interfaces, regenerative pathways, and translational benchmarks.

Journal of neuroengineering and rehabilitation·2026
Same author

Ferroptosis and Its Crosstalk with Other Cell Death Modes in Ischemic Stroke.

Current medicinal chemistry·2026
Same author

A Catalyst-Free Three-Component Approach to Sulfonated Indole-Fused Diazepinones via SO<sub>2</sub> Insertion.

The Journal of organic chemistry·2026
Same author

Bidirectional Associations Between Frailty and Preeclampsia: A Two-Sample Mendelian Randomization Study.

International journal of women's health·2026
Same author

Mechanism and Origins of Chemo-, Regio-, and Stereoselectivities in NHC-Catalyzed Reaction of 1-Cyclopropylcarbaldehydes with α-Alkynyl Enals: A Theoretical Study.

The Journal of organic chemistry·2026
Same author

Kyphoscoliotic Ehlers-Danlos syndrome due to a novel homozygous PLOD1 variant: severe vascular involvement and molecular diagnosis.

BMC medical genomics·2026
Same journal

A planar dimer of bovine ATP synthase.

Cell death and differentiation·2026
Same journal

GCN5 and TADA2B constitutively regulate XRCC1 function during DNA repair to maintain cell survival.

Cell death and differentiation·2026
Same journal

MEGF8 controls osteogenic differentiation through post-transcriptional regulation of BMP-SMAD signaling in craniosynostosis.

Cell death and differentiation·2026
Same journal

Macrophage-secreted brain-derived neurotrophic factor promotes tumor growth in triple-negative breast cancer by inducing axonogenesis.

Cell death and differentiation·2026
Same journal

Species-specific regulation of necroptosis by STK38-dependent RIPK1 phosphorylation.

Cell death and differentiation·2026
Same journal

Ssu72 phosphatase orchestrates obesogenic adipogenesis and metabolic homeostasis during nutrient excess.

Cell death and differentiation·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

7.5K

Cell death in multiple sclerosis.

Shuzhen Guan1, Huimin Zhu1, Mengting Zhang2

  • 1Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.

Cell Death and Differentiation
|September 9, 2025
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis involves central nervous system inflammation and neurodegeneration. Targeting regulated cell death (RCD) pathways alongside inflammation offers a promising strategy to mitigate disease progression and neurodegeneration in MS.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.9K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.2K

Related Experiment Videos

Last Updated: Jan 18, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

7.5K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.9K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.2K

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Neuropathology

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune CNS disorder causing demyelination and neurodegeneration.
  • Current therapies inadequately prevent neuroinflammation and cell loss.
  • Regulated cell death (RCD) pathways are increasingly recognized as drivers of MS pathology.

Purpose of the Study:

  • To review the role of RCD mechanisms in MS neuroinflammation and neurodegeneration.
  • To summarize RCD's contribution to MS pathology across disease stages.
  • To discuss emerging therapeutic strategies targeting RCD in MS.

Main Methods:

  • Literature review of RCD pathways (apoptosis, necroptosis, pyroptosis, ferroptosis) in MS.
  • Analysis of RCD's contribution to cellular homeostasis disruption and immune activation via DAMPs.
  • Examination of therapeutic approaches targeting RCD components like RIPK1 and NLRP3.

Main Results:

  • RCD pathways actively drive demyelination, axonal injury, and glial dysfunction in MS.
  • RCD contributes to a self-amplifying loop of cell death and inflammation.
  • Distinct RCD forms can coexist in MS lesions, complicating pathology.

Conclusions:

  • RCD plays a critical role in MS pathogenesis, exacerbating neuroinflammation and neurodegeneration.
  • Targeting RCD, particularly in combination with anti-inflammatory approaches, holds therapeutic potential.
  • Inhibitors of key RCD mediators like RIPK1 and NLRP3 represent promising avenues for MS treatment.